Aims: This study aims to evaluate the clinical outcomes of three commonly used treatment methods—banding, nail brace, and the Winograd procedure—in patients with Heifetz stage 2 ingrown toenails. Parameters such as recurrence rate, infection rate, postoperative pain, and patient satisfaction were assessed to guide clinical decision-making.
Methods: This retrospective study included 91 patients diagnosed with Heifetz stage 2 ingrown toenail, who were treated using one of three methods. Patients were divided into three groups: banding, nail brace, and Winograd procedure. Visual Analog Scale (VAS) scores were recorded on the third postoperative day to assess pain levels. The short-term outcomes, recurrence rates, and complications were analyzed. Ethical approval was obtained and the study adhered to the principles of the Declaration of Helsinki.
Results: The nail brace method showed a significantly shorter return-to-work duration (mean 10.2±9.5 days) compared to the Winograd procedure (19.0±6.4 days, p<0.001). Postoperative pain levels were significantly lower in the nail brace group (VAS score: 4.1±1.3) than in the Winograd group (6.0±1.5, p<0.001). Recurrence rates were similar across the nail brace (25.0%), Winograd (15.0 %), and banding (26.1%) groups (p=0.472). No significant differences were observed in the postoperative infection rates between the two methods (p=0.571).
Conclusion: The nail brace method offers faster recovery, shorter return-to-work durations, and lower postoperative pain, making it a less invasive alternative to the Winograd technique, which has longer recovery times. Despite these differences, both methods show similar recurrence rates, highlighting the need for treatment selection based on patient characteristics and preferences. Further studies with larger samples are required to assess long-term outcomes.
Primary Language | English |
---|---|
Subjects | Orthopaedics |
Journal Section | Research Articles |
Authors | |
Publication Date | March 21, 2025 |
Submission Date | February 1, 2025 |
Acceptance Date | February 17, 2025 |
Published in Issue | Year 2025 Volume: 7 Issue: 2 |
TR DİZİN ULAKBİM and International Indexes (1b)
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/3449/file/4924/show
Journal Indexes and Platforms:
TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.The indexes of the journal's are;
The platforms of the journal's are;
The indexes/platforms of the journal are;
TR Dizin Ulakbim, Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, ICI World of Journal's, Index Copernicus, Turk Medline, General Impact Factor, Scilit
EBSCO, DOAJ, OAJI is under evaluation.
Journal articles are evaluated as "Double-Blind Peer Review"